You are viewing an incomplete version of our website. Please click to reload the website as full version.

DTL antibody (Denticleless E3 Ubiquitin Protein Ligase Homolog (Drosophila)) (AA 229-256)

Details for Product anti-DTL Antibody No. ABIN654926, Supplier: Log in to see
Antigen
  • 2810047L02Rik
  • 5730564G15Rik
  • CDT2
  • DCAF2
  • L2DTL
  • Ramp
  • RAMP
  • RGD1310439
Epitope
AA 229-256, Center
17
13
8
5
4
2
1
1
1
1
Reactivity
Human, Mouse (Murine)
42
11
7
1
1
Host
Rabbit
41
1
Clonality (Clone)
Polyclonal ()
Conjugate
This DTL antibody is un-conjugated
2
2
2
2
2
2
Application
Flow Cytometry (FACS), Western Blotting (WB)
36
19
15
6
5
4
2
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen This DTL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 229-256 AA from the Central region of human DTL.
Clone RB24420
Isotype Ig
Specificity This DTL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 229-256 amino acids from the Central region of human DTL.
Purification This antibody is purified through a protein A column, followed by peptide affinity purification.
Alternative Name DTL (DTL Antibody Abstract)
Background Substrate-specific adapter of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex required for cell cycle control, DNA damage response and translesion DNA synthesis. The DCX(DTL) complex, also named CRL4(CDT2) complex, mediates the polyubiquitination and subsequent degradation of CDT1 and CDKN1A/p21(CIP1). CDT1 degradation in response to DNA damage is necessary to ensure proper cell cycle regulation of DNA replication. CDKN1A/p21(CIP1) degradation during S phase or following UV irradiation is essential to control replication licensing. Most substrates require their interaction with PCNA for their polyubiquitination: substrates interact with PCNA via their PIP-box, and those containing the 'K+4' motif in the PIP box, recruit the DCX(DTL) complex, leading to their degradation. In undamaged proliferating cells, the DCX(DTL) complex also promotes the 'Lys-164' monoubiquitination of PCNA, thereby being involved in PCNA-dependent translesion DNA synthesis.
Synonyms: Denticleless protein homolog,DTL,CDT2, CDW1, DCAF2, L2DTL, RAMP
Molecular Weight 79468 DA
Gene ID 51514
NCBI Accession NP_057532
UniProt Q9NZJ0
Research Area Ubiquitin-related antibodies, Phospho-specific antibodies, Cell Structure, Protein Modifications, Chromatin, Signaling
Application Notes WB = 1:1000, FACS = 1:10-50
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer PBS with 0.09 % (W/V) sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date 6 months
Supplier Images
Flow Cytometry (FACS) image for anti-DTL antibody (Denticleless E3 Ubiquitin Protein Ligase Homolog (Drosophila)) (AA 229-256) (ABIN654926) DTL Antibody (Center) (ABIN654926) flow cytometric analysis of Hela cells (right hist...
Background publications Centore, Havens, Manning, Li, Flynn, Tse, Jin, Dyson, Walter, Zou: "CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase." in: Molecular cell, Vol. 40, Issue 1, pp. 22-33, 2010 (PubMed).

Abbas, Shibata, Park, Jha, Karnani, Dutta: "CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation." in: Molecular cell, Vol. 40, Issue 1, pp. 9-21, 2010 (PubMed).

Abbas, Sivaprasad, Terai, Amador, Pagano, Dutta: "PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex." in: Genes & development, Vol. 22, Issue 18, pp. 2496-506, 2008 (PubMed).